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Posttraumatic stress disorder (PTSD) is a trauma and stress related disorder 
that some people develop after exposure to a traumatic life altering event. 
The person must witness the traumatic event, have the traumatic event occur 
to a loved one, or experience a traumatic event first hand. According to the 
publication of the American Psychiatric Association, the fifth edition of the 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5), the 
diagnostic criteria for the identity of PTSD must include behavioral symptoms 
that accompany PTSD in four diagnostic clusters; re-experiencing, avoidance, 
negative cognitions and mood, and arousal (American Psychological 
Association, 2018). Two of the most common demographics affected by PTSD 
are survivors of sexual assault and combat war veterans and these are 
typically cached together. Yet, preliminary investigation suggests while there 
is overlap in manifestation of the disease, there may be important differences 
depending on the context in which the events took place: military versus 
sexual assault. Scientific literature will be used to create an in-depth 
comparison of the similarities and differences in symptoms and physiological 
impacts of PTSD between sexual assault survivors and combat war veterans. 
Specifically, this study will focus on differences and also the identification of 
biomarkers of chronic pain, addiction and assessment of immune function. 




The desired outcome is to develop a better comprehension of PTSD and work 
towards public awareness of the differences between sexual and war combat 
PTSD.  This will result in facilitating a more accurate and successful 
understanding of treatment for individuals who are experiencing symptoms 
of PTSD.   





Individuals who have survived sexual violence or were involved in 
wartime combat experience rates of Posttraumatic stress disorder (PTSD) 
estimated to be between 10-40 percent higher compared to the general 
population (Brunet & Sareen, 2015). According to the Diagnostic and 
Statistical Manual of Mental Disorders, 5th Edition, (DSM-5), PTSD is a 
trauma and stress related disorder that some people develop after exposure 
to a traumatic life altering event. To be diagnosed with the disorder, an 
individual must witness a traumatic event, have the traumatic event occur to 
a loved one, or experience a traumatic event first hand. The fifth edition of 
the Diagnostic and Statistical Manual of Mental Disorders (DSM-5), states 
that the diagnostic criteria for the identification of PTSD must include 
behavioral symptoms that accompany PTSD in four diagnostic clusters; re-
experiencing, avoidance, negative cognitions and mood, and arousal 
(American Psychological Association, 2018).   
  Chronic pain is often reported in patients who have PTSD (Noel et al., 
2016). Additionally, PTSD and substance abuse are prevalent and often co-
occur (McCauley et al., 2012). Furthermore, individuals afflicted with PTSD 
have biological alterations in their primary pathways of neuroendocrine and 
immune function (Neigh & Ali, 2016). Therefore, this review will first focus 
on the neurobiological and anatomical characteristics of PTSD and then 




identify the two primary demographics, combat war veterans and survivors 
of sexual abuse, that have been investigated in this study. The three 
conditions that are often co-morbid with PTSD and each other: chronic pain, 
addiction, and immune disorders, will then be discussed in relation to PTSD.  
Furthermore, this review will discuss the extent to which these co-
morbidities differentially impact sexual assault survivors with PTSD and 
combat war veterans with PTSD.  Finally, data will be presented describing 
the discrepancy in PTSD related research for these populations. Comparison 
of the similarities and differences between these two groups provides 
intrinsic benefits in forming a holistic understanding of PTSD. 
 
Clinical Definition of PTSD 
The newest edition of the American Psychiatric Association’s (APA) 
Diagnostic and Statistical Manual of Mental Disorders (DSM-5) has recently 
altered the criteria for the positive diagnosis of PTSD. Diagnostic criteria for 
the identity of PTSD must include behavioral symptoms that accompany PTSD 
in four diagnostic clusters; re-experiencing, avoidance, negative cognitions 
and mood and arousal. The precipitating event must be identified as an 
exposure to sexual violation, serious injury, or threatened death. The 
exposure to the precipitating event must result from a direct experience to a 
traumatic event; first hand repeated or extensive exposure to extreme details 




of a traumatic event (not through movies unless work-related, television, 
pictures, or through media); witness a traumatic event in person; or learning 
of a traumatic effect that has affected a close friend or family member. The 
traumatic event must be persistently experienced in one of the following 
ways; flashbacks of the event, nightmares, unwanted upsetting memories, or 
emotional distress or physical reactivity after exposure to a traumatic 
reminder. In addition, the person must have an avoidance tendency of trauma 
related stimuli after the event such as trauma related external reminders or 
trauma related thoughts or feelings. The negative thoughts or feelings the 
person has towards the event must have begun or became exacerbated after 
the trauma in at least two of the following ways; exaggerated blame of one’s 
self or others for causing the trauma, the inability to recall key features of 
the trauma, a pessimistic view about oneself or the world, feeling of 
isolation, negative affect, struggling to experience positive effect, and a 
reduced interest in activities.  
PTSD has been correlated with both situations involving a single 
specific brief traumatic event, and also with situations involving long term 
patterns of regular abuse or trauma and chronic victimization.  While studies 
have correlated age at the precipitating trauma with the resulting PTSD 
phenotype, it has still not been definitively determined what affect if any that 
this time frame for trauma has. 




In addition, the individual must have at least two of the following 
alterations in arousal and reactivity that started or increased after the 
trauma: (1) difficulty falling or staying asleep, problems concentrating, 
impulsive, risky or destructive behaviors, aggression or irritability, 
heightened startle responses, or (2) a sensation of hypervigilance believing 
danger is constantly present. These symptoms must last for more than one 
month and must also create a functional impairment or clinically significant 
distress in the person’s social interactions, their ability to work, or other 
crucial areas of functioning. PTSD is a trauma and stress-related disorder 
that frequently co-occurs alongside other disabling psychiatric and physical 
conditions (Shipherd et al., 2007). Due to these frequent co-morbidities, it is 
important to note that these symptoms cannot be a physiological result of 
substance use, medication, or other illness (American Psychiatric 
Association., 2013).  
 
Neurobiology of PTSD 
One of the factors that has been the source of confusion and 
controversy in the understanding of PTSD, is the complex nature of the 
neuroendocrine, neuroanatomical, and neurochemical effects it has on the 
human brain and body.  The underlying neurobiology of PTSD involves the 
neuroendocrine stress response and the sympathetic nervous system and 




impacts several brain areas.  The hormone, cortisol, which is a glucocorticoid 
is the primary driving component of neuroendocrine system hypothalamic-
pituitary-adrenal axis (HPA axis), while adrenaline (also called 
“epinephrine”) is the driver of the sympathetic nervous system (Rege, 2017). 
 
The Sympathetic and Parasympathetic Nervous Systems: 
The sympathetic nervous system is responsible for the “fight or flight” 
response that the body has developed to respond to acute stresses. 
Respectively the parasympathetic nervous system is responsible for returning 
the body to a state of “rest and digest”.  These systems typically balance each 
other out allowing intense sudden responses to stress while also allowing 
long term physiological stability (Figure 1).  These involuntarily controlled 
systems are also responsible for the regulation of the catecholamine 
neurotransmitters: norepinephrine and epinephrine. The release of these 
chemical messengers increases oxygen consumption, heart rate, blood 
pressure, pupillary dilation, stimulates sweat secretion, and causes blood 
flow to facilitate glucose and oxygen coming together to form ATP (Sapolsky, 
2004).  Furthermore, this “fight or flight” response has a biphasic effect on 
the immune system. In general, it initiates aspects of innate immunity such 
as reducing inflammation to destroy antigens, pathogens and foreign 




invaders whereas it tends to divert resources from long-term adaptive 
immunity (Hannibal & Bishop, 2014). 
Concurrent with the activation of the sympathetic nervous system is 
often activation of the HPA which promotes the release of cortisol, a 
glucocorticoid which has receptors expressed in nearly every cell type.  
Cortisol is a lipophilic hormone responsible for the regulation of glucose 
levels (hence the label “glucocorticoid”) that is capable of crossing the blood 
brain barrier thus directly affecting the brain.  In times of stress, the body 
has an increase in its need of the cell’s energy molecule, adenosine 
triphosphate (ATP) (Bremner et al., 1995), within areas specifically but not 
limited to those involved in the control of fear and aggression such as the 
amygdala, those related to learning and memory especially the hippocampus, 
and in voluntary muscle functions which may be necessary for “flight” or 
movement in order to avoid danger.   
In typical reactions to acute stress, about 15 minutes after the stressful 
event, the levels of cortisol diminish, and the parasympathetic system takes 
over promoting the process of “rest and digest”—a neuroendocrine response 
to restore homeostasis. This system promotes energy storage, growth, rest, 
adaptive immunity and processes that slow the body down (Sapolsky, 2004).  
Individuals with PTSD however, do not transition from a state of “fight or 




flight” to “rest and digest” in a typical manner due to inhibition of the 
normalization in cortisol levels. 
 
Figure 1.  Overview of the sympathetic and parasympathetic nervous systems.  
In individuals with PTSD, activation of the sympathetic nervous system is not 
appropriately balanced by the parasympathetic nervous system due to 
sustained elevations in cortisol levels due to the HPA axis.  This prevents the 




individual from transitioning typically from a “fight or flight” state to a “rest 
and digest” state (Geo-Science-International, 2016). 
 
Hypothalamic-Pituitary-Adrenal Axis: 
 The hypothalamic-pituitary-adrenal (HPA) axis, is largely responsible 
for the physiological responses to heightened levels of stress.  In times of 
increased levels of stress, the hypothalamus initiates a chain of neurological 
and chemical events. Within the hypothalamus, the periventricular nucleus 
(PVN) secretes corticotrophin-releasing hormones (CRH), which causes the 
anterior pituitary to release adrenocorticotropic hormone (ACTH). This then 
travels to the adrenal cortex and in response causes the release of 
corticosteroids (Cortisol) (Figure 2).  
 





Figure 2. Hypothalamic-Pituitary-Adrenal Axis Pathway. The hypothalamus 
releases corticotropin releasing hormone (CRH), which leads to the anterior 
pituitary to release adrenocorticotropic hormone (ACTH), followed by the 
adrenal cortex releasing cortisol.  In individuals with PTSD, long-term 
activation of this pathway either dampens responses or downregulates 
glucocorticoid receptors (BrianMSweis, 2012). 
 
 




In individuals with PTSD, the typical balance of this hormonal cascade 
is altered.  The HPA axis prevents the parasympathetic nervous system 
response from initiating in a typical manner resulting in sustained release of 
cortisol perpetuating the stress response. These individuals have a 
heightened resting level of CRH which causes a reduced ACTH response that 
ultimately leads to a reduction in overall glucocorticoid signaling (Rege, 
2017). 
Prolonged increased levels of cortisol can result in a compensation of 
down-regulation or resistance of the glucocorticoid receptor that blocks the 
binding of cortisol.  The overall effect of this is the reduction in signaling 
leading to the failure of cortisol to function properly. This will also prevent 
negative feedback resulting in sustained higher levels of CRH. 
 
Neuroanatomical structures involved in fear and memory 
 In addition to the neurochemical changes identified in individuals with 
PTSD, several neuroanatomical changes are prevalent. Brain imaging has 
shown fundamental alterations in structures associated with stress and fear 
conditioning in individuals suffering from PTSD.  Some of the most notably 
altered structures include the hippocampus, amygdala, and the prefrontal 
cortex (Yehuda et al., 2015). 






 The hippocampus is the primary site of learning and memory within the 
brain, wherein the neurotransmitter glutamate assists in the formation of 
short-term and long-term memories through long-term potentiation.  This is 
affected by multiple factors one of which being the cortisol level present. 
Cortisol increases the release of glutamate and has been shown to be 
responsible for “flash-bulb” memories that take place in response to 
increased levels of stress (Popoli, Yan, McEwen, & Sanacora, 2011).  Like 
many situations in which the brain will attempt to correct a perceived 
imbalance, studies have shown that stress increases the level of baseline 
glucocorticoids and that the release of cortisol specifically can increase the 
time required to process and learn new skills or information. In animal 
studies, elderly mice learned a maze more slowly when they possessed 
elevated blood levels of glucocorticoids compared to those who possessed 
average levels of glucocorticoids.  The long-term exposure of glucocorticoids 
was proven to destroy hippocampal neurons (Yau & Seckl, 2012). Similar to 
what takes place in the victim of a stroke, an abnormal elevation of glutamate 
can cause over excitation of the post synaptic cells which may result in the 
death of the neuron.  The hippocampus also is a key factor in the conditioning 
of stress responses, declarative memory, and fear extinction. There has been 




a strong correlation between a reduction in hippocampal volume and the 
incidence of PTSD in an individual.  This correlation has recently come under 
scrutiny bringing debate to whether the decrease in hippocampal volume is a 




 The processing of stressful stimuli, emotional processing and 
association of fear responses is most directly affected by the amygdala.  
Glutamate transmission is increased in times of stress.  Due to this increase 
in glutamate transmission, any future exposure to traumatic events or 
associations connected to the initial event initiate a fear-based response.                                                       
Individuals with PTSD can display both hypo-activity and hyper-activity 
within the amygdala sub-nuclei.  Studies have shown that even in episodes of 
prenatal stress, fetuses that grow to adulthood develop similar physiological 
responses to those who suffer trauma at later stages of their lives.  In studies 
with rats, such fetuses that were subjected to regular stress over the last 
week of their mother’s pregnancy, displayed an approximately 30 percent 
increase in amygdala volume when compared to fetuses of rats that had not 
been subject to routine stress (Harmon, et al, 2009).  Structurally, MRI 
analysis and a study focused on the brains of monkeys under continuous 




stress, have displayed both an overall general increase in the amygdala size, 
and pathological damage caused by hyper-responsiveness to perceive 
threatening stimuli (Uno, Tarara, Else, Suleman, & Sapolsky, 1989).  These 
results indicate a long-term neurological alteration of an individual’s ability 
to consistently and accurately interpret stimuli in stressful situations.  
 
Prefrontal Cortex: 
 The prefrontal cortex is responsible for the modulation of behaviors 
potentially via its role in working memory.  An individual’s ability to 
distinguish appropriate behavior within a given context is highly regulated 
through the prefrontal cortex.  As shown in Figure 3, the prefrontal cortex is 
adjacent to the amygdala and both areas of the brain have a bilateral ability 
to directly affect each other.  The prefrontal cortex is responsible for the 
inhibition of acquired fear responses allowing fear extinction to be possible.  
Along with displaying a general reduction in prefrontal cortex volume, the 
ability to inhibit the control of the amygdala’s stress response system is 
shown to be decreased in individuals experiencing PTSD.  Children who had 
experienced emotional maltreatment had a 7.2% reduction of the volume of 
their prefrontal cortex on average (van Harmelen et al. 2010). 
This reduction in inhibitory function often results in a lesser degree of 
control over responses to traumatic associations leading to the individuals re-




experiencing of precipitating traumatic events in various forms from 
increased anxiety to “flash backs”. It was found in a functional imaging study 
that when individuals with PTSD were shown faces with fearful expressions, 
they displayed increased activation in the amygdala and a decreased 
activation in their prefrontal cortex when in comparison to individuals not 
experiencing PTSD (Shin et al., 2005).  One group of researchers concluded 
that the prefrontal cortex is considered to be the structure responsible for 
controlling an individual’s behavior and reactions, and in individuals with 
PTSD, the prefrontal cortex can have such a diminished level of function that 
often, rather than being responsible for emotional reactions, the amygdala 
alone is considered as the overall controlling body for such responses (Rauch, 
Shin, & Phelps, 2006). 





Figure 3.  Brain areas affected in PTSD.  In PTSD the relationship between the 
amygdala and the prefrontal cortex is altered manifesting in either 
overmodulation of the amygdala emotional processing by the prefrontal cortex, 
or an inability to regulate emotional processing or fear responses from the 








Prefrontal Cortex-Amygdala: Emotional Overmodulation and 
Undermodulation: 
 One factor that has caused much controversy in the diagnosis of PTSD is 
its ability to manifest itself in seemingly opposite response types.  The two 
primary phenotypes of PTSD are emotional undermodulation and emotional 
overmodulation.  Emotional undermodulation is represented by a reduced 
prefrontal cortex inhibition, increased emotional autonomic responses, and 
an increased level of amygdala activity.  Alternately, individuals experiencing 
emotional overmodulation tend to have an increased level of prefrontal 
cortex (PFC) inhibitory function, an emotional detachment, numbing or 
depersonalization, and an increase in prefrontal cortex activity coupled with 
a reduction in amygdala responses.  The seemingly paradoxical nature of 
these two primary phenotypes has been the source of much confusion when 
diagnosing and treating PTSD.  While both are displayed in seemingly 
opposite ways, they both are consistent in their areas of neuro-anatomic and 
neurochemical areas of modification (Yehuda et al., 2015). 
 
PTSD Precipitating from Sexual Abuse 
 Sexual abuse PTSD can be acquired from several different situations. 
According to rainn.org, every 98 seconds an American is sexually assaulted. 




The three main forms of sexual abuse that have a tendency to precipitate 
PTSD include, Child sexual abuse and assault, Sexual Assault (SA), and 
Intimate Partner Violence (IPV). Unlike the recently, widely publicized and 
accepted attribution of PTSD in combat war veterans, PTSD in survivors of 
sexual abuse, is often either undiagnosed or an individual’s symptoms are 
considered to be predominantly psychological rather than deeply rooted in 
physiological changes resulting from psychological and trauma-based 
precipitating incidences. This discrepancy in demographic-based association 
of PTSD can be shown by the disproportional representation of title keywords 
within published studies from the scientific community as shown in (Figure. 
4).  Additionally, the association with shame and embarrassment weighs 
heavily on the statistical representations of individuals who have been 
victims of sexual abuse.  In 1993, it had been believed that the percentage of 
women with a history of rape in the United States could be as high as 12.9% 
(Moser, Hajcak, Simons, & Foa, 2007) while a population of young adults 
studied in Detroit yielded a 1.6% prevalence of rape reported (Breslau, Davis, 
Andreski, & Peterson, 1991). 
 





Figure. 4 Graph comparing articles published and cited in PubMed with titles 
containing relevant keywords in total and over the past five years. All searches 
were run requiring the presence of both PTSD and the relevant keywords in the 
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 Sexual assault (SA), including and not limited to rape, is any act of 
sexual contact or behavior that is not expressly permitted by the victim and is 
estimated to impact 17.6% of women and 3.0% of men in the United States 
(Tjaden & Thoennes, 2000).  Intimate partner violence (IPV) is a sub 
classification of sexual assault wherein the transgressing individual is 
someone the victim is personally familiar with and may or may not have had 
a previous or current sexual or emotional connection with.  It is estimated 
that IPV is experienced by 21.7% of women and 7.3% of men in the United 
States.   
A sub classification of IPV that can cause PTSD is known as military 
sexual trauma (MST). Military sexual trauma is a form of high betrayal 
trauma because the social agreement of trust is broken for the violated victim 
due to their dependency on the perpetrator for survival. The victim is unable 
to leave, confront, or break ties with the perpetrator due to their military 
connection. This connection and betrayal damage the victim’s wellbeing and 
their overall view of the world leading to PTSD. The victim is subjected to 
trauma by someone who was meant to help them develop as individuals and 
soldiers. Escaping the perpetrator may be difficult and lead to more 
violations, interpersonal violence, rape, and continued exposure and 
involvement with the perpetrator leading to long term consequences. Women 
who experience military sexual assault have higher rates of PTSD than 




women who have been subjected to other types of trauma. MST has been 
reported to affect 40% of female veterans. The number is uncertain due to 
many veterans not reporting incidences (Lutwak & Dill, 2013). 
While both forms of sexual violence, IPV and SA, are concerning adult 
men and women, SA has shown to be significantly more likely to increase 
symptom severity across multiple symptom clusters (Dworkin, Mota, 
Schumacher, Vinci, & Coffey, 2017).  An individual’s experiencing of IPV 
however, has been shown to be a less consistent indicator in the development 
of PTSD symptom clusters when regarding other forms of sexual violence.  SA 
and IPV also display differences in their tendencies of phenotype 
manifestation.  
Individuals suffering from PTSD due to an IPV-based precipitating event 
have shown a tendency to behave in manner consistent with chronic 
victimization. These individuals tend to behave in active avoidance 
subscribing more typically to the PTSD phenotype of Emotional 
Undermodulation. SA survivors on the other hand have a greater tendency to 
display tendencies of passive avoidance and emotional numbing depicting a 
greater predisposition to fall within the classification of Emotional 
Overmodulation PTSD (Matlow & DePrince, 2013).   
Military sexual trauma has many similar components to the arguably 
most consistent form of sexual violence related PTSD precipitating events, 




child sexual assault.  Every year 63,000 children are sexually abused. Sixty-
six percent of sexual assault and rape victims are children ages 12-17 
(Morgan, 2017). Classification of an act of sexual assault of a child is 
considered to be when the child is involved in sexual activity in order to 
provide sexual gratification to the perpetrator. This includes exposure to 
pornography, use of the child for prostitution, sexual based touching, and 
acts of sexual non-touching such as exhibitionism, photography of the child 
for sexual gratification, and communication in a sexual way face to face, by 
internet, or by phone. Children’s sexual abuse can involve molestation, incest, 
prostitution, statutory rape, pornography, or other sexual activities (Murray, 
Nguyen, & Cohen, 2014).  
A study conducted in an Israeli out-patient ambulatory center found 
that of individuals who had experienced sexual abuse under the age of 16, 
61.4% experienced a prolonged effect that had persisted until the time of 
study.  When comparing the prevalence of continuing or prolonged effects as 
a result of childhood sexual abuse to that of Holocaust survivors (33.3%), 
victims of car accidents (34.8%), and veterans of the Gulf War (8.9%), the 
impact of sexual abuse during childhood is staggering (Gaon, Kaplan, 
Dwolatzky, Perry, & Witztum, 2013).  Furthermore, this study powerfully 
highlights the potential lack of proper diagnosis in the area of PTSD in 
victims of sexual abuse.  While nearly 11% of the 456 individuals who 




reported a moderate to severe effect of traumatic events displayed a 
prolonged and current debilitating effect from the initial trauma, only 3.3% 
of the individuals who had been diagnosed with PTSD had been victims of 
sexual abuse.  Respectively, in the same study, some of the most largely 
represented groups of individuals with PTSD reported sexual abuse to have 
occurred much more significantly.  The presence of sexual abuse was 
reported to be 21.5% in individuals with major depression, 18.8% in those 
with bipolar disorder, 20.8% in respondents with personality disorder, and 
19.4% in those suffering from psychotic disorder (Gaon, Kaplan, Dwolatzky, 
Perry, & Witztum, 2013). 
It is also notable that it has been shown that individuals suffering from 
PTSD resulting from traumas such as chronic childhood abuse or other long 
term precipitating traumatic events more often display symptoms of 
emotional overmodulation resulting in symptoms of dissociation when 
compared to individuals suffering more acute precipitating traumas (Lanius 
et al., 2010). Studies have linked PTSD symptoms to childhood sexual abuse 
particularly those of posttraumatic fear, anxiety, and concentration.  
Research assessing sexually abused children has found up to a 48% increase 
in a diagnosis of PTSD when compared to children who had not been sexually 
abused (Briere, & Elliott, 1994).  Despite the fact that the majority of child 
sexual abuse victims do not meet full PTSD diagnostic criteria, over 80% of 




individuals experiencing such abuse have reported PTSD symptoms.   Adults 
who were childhood sexual abuse victims have been shown to consistently 
show increases in avoidant, arousal, and intrusive symptoms of PTSD when 
compared to individuals who did not experience abuse as a child. Adult 
survivors of childhood sexual abuse have shown a prominent tendency to 
experience various forms of flashbacks. Sudden intrusive visual, auditory, 
tactile or olfactory sensory experiences reminiscent of the PTSD precipitating 
trauma often lead to vivid and intense flashbacks strongly leaving those 
suffering with the feeling that the events were actually presently occurring 
rather than just a recalled memory (Briere, & Elliott, 1994). 
 
PTSD Precipitating from Combat War Exposure in Veterans 
 The prevalence of PTSD in combat war veterans has been highly 
publicized and the focus of intense discussion and study in the recent past 
(Figure 4).   This increase in public attention has been a driving force for 
further identification and treatment of PTSD in combat war veterans.  While 
studies have varied significantly on concrete statistics of PTSD prevalence 
percentages, the rate of lifetime PTSD within combat war veterans is 
approximately two to four times higher than the general population (Gros, 
Szafranski, Brady, & Back, 2015). The National Vietnam Veterans 
Readjustment Study states that 30 percent of veterans have had PTSD at some 




point during their lifetime which can persist many decades after the initial 
combat exposure (Shipherd et al., 2007).  In the past 13 years, there have 
been as many as half a million U.S. troops who served in Iraq or Afghanistan 
that have been diagnosed with PTSD.   
 Intrinsically, combat war is a source of countless potential sources of 
trauma that could become precipitating incidences for the formation of PTSD 
in those exposed.  Modern warfare and its tendency to trend more in favor of 
complex guerilla tactics, has posed several new areas of potentially 
heightened trauma exposure levels that could result in PTSD of the 
individuals experiencing them.  Some sources of trauma that could 
precipitate the development of PTSD include but are not limited to; fear and 
trauma resulting from improvised explosive devices, a lack of clearly defined 
areas of conflict and safety, unpredictable urban-style guerrilla attacks and 
an increase in overall average exposure to a consistently traumatic 
environment (Reisman, 2016). 
 Specifically, study has been focused on a dissociative PTSD subtype now 
recognized as the emotional overmodulation phenotype of PTSD. While it was 
expected that PTSD symptoms would fall in line with the more common form 
of PTSD consisting of emotional undermodulation resulting in hyper arousal 
and re-experiencing symptoms, a 2014 study provided surprising results.   A 
study was conducted of 63 U.S. soldiers four months after returning from 




deployment in Iraq.  This was the first study to demonstrate the interaction 
between attentional threat avoidance, behavior health symptoms during the 
post-deployment period and combat exposure.  The resulting data posed the 
possibility that attentional avoidance (the directing of one’s focus opposite 
the location of a threatening cue) of threat stimuli may be a robust 
phenomenon among symptomatic populations of individuals who are or have 
recently experienced highly stressful combat events.  This display of 
attentional avoidance was a notable contradiction to the typical patterns of 
enhanced vigilance seen in patients diagnosed with PTSD (Sipos et al. 2014).  
A recent fMRI and script-driven imagery test conducted while individuals 
with PTSD were led to recall their traumatic experience showed that 
approximately 70% of patients displayed an increase in heart rate and had 
the subjective experience of reliving their traumatic experience.  
Respectively, the remaining 30% of the individuals with chronic PTSD tested 
displayed a dissociative response consisting of a subjective state of 
depersonalization and de-realization while showing no notable increase in 









 Chronic pain is often comorbid with PTSD and as is generally the case, 
when looking at the two populations most affected by PTSD, most of the 
research on pain has been conducted with combat veterans (Figure 5). 
Chronic pain is any form of pain lasting more than 12 weeks.  Individuals 
with PTSD display consistently lower levels of cortisol. Cortisol is a potent 
anti-inflammatory and the desensitization promotes abnormal inflammation 
in response to pro-inflammatory stresses. In individuals with cortisol 
dysfunction, upon the activation of an acute inflammatory stress response, 
widespread inflammation often follows (Hannibal & Bishop, 2014).  
Furthermore, the failure of cortisol to function properly limits the body’s 
ability to reduce such inflammation which can lead to the production of free 
radical byproducts and stress damage to healthy tissues. Inflammation is also 
capable of widening the gap junctions in the blood brain barrier and 
intestinal lining.  This widening can allow large foreign bodies or toxins to 
breach protective barriers and may result in illness (Sorrells, Caso, Munhoz, 
& Sapolsky, 2009).  
One definitive aspect of the body’s inflammatory response is the 
sensation of pain. Patients suffering from chronic pain tend to process pain in 
emotion-related circuits, also responsible for the reward processing, more 
actively than those with acute pain preceding recovery (Hashmi et al. 2013).  




This was inferred from the substantial increase to activation overlap of brain 
emotional processing areas such as the prefrontal cortex and amygdala with 
regions involved in acute pain when imaging chronic pain patients.   This 
increased interconnection highlights a correlation between reorganization in 
the reward and motivational circuits when related to the emotional circuits of 
the brain, leading to the possibility of their interconnectivity and explaining 
co-morbid disorders such as PTSD in chronic pain patients (Navratilova et al., 
2016).   
The connection of the reward centers of the brain to the prefrontal 
cortex and amygdala, which is responsible for the balance dysfunction in 
individuals with PTSD, has been shown to decrease dopamine release in 
response to pain. Individuals with fibromyalgia did not release dopamine in 
response to noxious stimulation whereas individuals not suffering from 
reward pathway dysfunction showed dopamine release when self-reported 
pain was induced (Wood et al., 2007).  This self-reported pain correlated 
with dopamine amounts released in the basal ganglia.  
PTSD alongside chronic pain are often comorbid (Gros, Szafranski, 
Brady, & Back, 2015) in veterans. Almost 50% of veterans have reported 
experiencing some sort of frequent chronic pain regularly (Kerns, Otis, 
Rosenberg, & Reid, 2003). According to Morasco et al. (2013), in a sample of 
205 military veterans, 32% had chronic pain with comorbid PTSD. Veterans 




were divided into two groups, those with PTSD and those without PTSD. The 
group of veterans with PTSD reported a remarkably higher pain severity and 
pain interferences than those without PTSD. The most common types of 
chronic pain within veterans who suffer from PTSD is neck or joint pain, 
lower back pain and rheumatism/arthritis, in that order. 
Additionally, in the study by Alschuler & Otis (2014), 198 veterans were 
surveyed for their pain levels. Veterans with comorbid pain and severe PTSD 
symptoms were found to have a lower differentiation between mild and 
moderate pain, whereas the cutoff between moderate and severe pain 
remained the same. Lower levels of pain intensity are connected to higher 
levels of pain-related interference in veterans with comorbid pain and severe 
PTSD symptoms when compared to veterans with pain without severe PTSD 
symptoms. Consequently, physicians should take into account PTSD 
symptoms when assessing a veteran’s pain severity. Male veterans with 
combat- related PTSD have a decreased sensitivity to pain when compared to 
women who suffer from PTSD from intimate partner violence (Strigo et al., 
2010). 
In a study performed by Meltzer-Brody et al. (2007), 713 women were 
administered a questionnaire when they were seen for pelvic pain. Roughly 
35% of participants who suffer from chronic pelvic pain were sexually 
abused with one in three women having been diagnosed with PTSD. The 




psychiatric comorbidity of chronic pain and PTSD may contribute to the 
woman's severity in pain levels.  PTSD resulting in sexual assault has been 
shown to display increased levels and regularity of abdominal pain, chest 
pain, pelvic pain and genital pain (Yeh, Watanabe, Sulkes-Cuevas, & 
Johansen, 2018). A nationwide survey of female veterans found PTSD is 
associated with at least one medical condition often involving pain. Arthritis 
and chronic lower back pain were the most common (Price, McBride, Hyerle, 
& Kivlahan, 2007).  Women with PTSD have a higher chance of reporting 
their pain as severe when compared to women who do not have PTSD. In 
turn, gynecologists can create specific treatment interventions for patients 
who have chronic pelvic pain and PTSD instead of treating them alongside 
patients without PTSD (Yeh, Watanabe, Sulkes-Cuevas, & Johansen, 2018). 
Countless studies have been done on the comorbidity of chronic pain 
and PTSD however statistical estimates of the prevalence of this correlation 
vary widely.  Studies have shown that; 50 to 75% of patients present for 
PTSD treatment also suffer from chronic pain, 80% of combat veterans with 
PTSD report chronic pain, 20-37% of individuals reporting chronic pain 
suffer from PTSD, and most recently that a sample of veterans serving in 
Operation Iraqi Freedom, Operation Enduring Freedom and Operation New 
Dawn displayed a 12.6% comorbidity of chronic pain and PTSD. Extensive and 
disproportionate study has been focused on pain and PTSD in the veteran 




community (Figure. 5) which could lead to a greater understanding of forms 
of PTSD more frequently identified in veterans.  Despite the clear positive 
correlation between PTSD and chronic pain in general, the actual pathways 
and mechanisms responsible for such atypical pain sensitivities and 
persistence remain obscure (Scioli-Salter et al., 2016). Additionally, 
individuals who have PTSD and comorbid chronic pain tend to have more 
severe pain than those with chronic pain alone (Morasco et al., 2013).  
 
Figure 5.  Graph comparing articles published and cited in PubMed with titles 
containing both relevant keywords and pain in total and over the past five 
years. All searches were run requiring the presence of both pain and the 














PubMed Document Totals Containing Both Pain and 
Specific Title Keywords
As of 2019 In past 5 years




Research on the PTSD and chronic pain relationship has suggested that 
these alterations to frequency and perceived intensity of pain are the result 
of both biological and psychosocial factors including but not limited to: 
depression, anxiety, physical disability, and a negative outlook on life 
control. Unfortunately, despite the various biopsychosocial models proposed 
to explain the comorbidity of PTSD and chronic pain, there is minimal data on 
the actual neurobiological influences on the holistic physiological system.  
Recent studies have proposed the contribution of abnormal deficits of 
neuropeptide Y (NPY) and the neuroactive gamma-amino butyric acid 
(GABA)-ergic steroids allopregnanolone and its stereoisomer pregnanolone 
which when together are considered (ALLO).  These hormones are known to 
play a role in control of stress responses, and individuals suffering from PTSD 
have lower levels of these stress-buffering molecules.  Cortisol and the 
androgen, dehydroepiandrosterone (DHEA) also could be potential influences 
on the perceived intensity and frequency of chronic pain and PTSD symptoms.  
Cortisol and the HPA axis have been concretely linked to the neurobiological 
systems affecting pain and PTSD. DHEA is secreted simultaneously with 
cortisol secretion and negatively modulates (GABAA) receptor function, 
reducing the effectiveness of the previously mentioned benefits of increased 
ALLO levels. This DHEA response to cortisol displays a possible mechanism 
for balancing the pain inhibitory effects of ALLO with the typical pain 
reduction due to the release of cortisol in individuals without a cortisol 




dysfunction.  In individuals with PTSD however, the reduction in cortisol 
effectiveness creates an imbalance in overall pain reduction due to DHEA’s 
reduction in pain inhibition resulting from increased levels of ALLO.  This 
results in the need for individuals suffering from PTSD to have a means to 
inhibit DHEA’s effect on ALLO in order to experience benefits due to their 
increased overall levels of cortisol (Scioli-Salter et al., 2016).  
  These complex and interconnected neurobiological mechanisms have 
the potential to serve as therapeutic targets in both the mitigation of PTSD 
and chronic pain symptoms.  Studies conducted have correlated increases in 
ALLO to a reduction in activity of the amygdala thus potentially reducing the 
tendency for the amygdala to overcome the prefrontal cortex in individuals 
with emotional undermodulation type PTSD. Inversely, this reduction in 
amygdala activity could also have the potential to exacerbate symptoms of 
emotional overmodulation PTSD.  There is also evidence that increased 
plasma levels of allopregnanolone leads to increased connectivity between 
the prefrontal cortex and the amygdala resulting in a reduction of anxiety.  
This reduction in anxiety displays significant potential for emotion regulation 









 Addiction has proven to be extremely prevalent in individuals who 
suffer from PTSD.  The development of coping mechanisms is a common 
response to stressful situations.  Along with general methods of avoidance, 
those suffering from PTSD often attempt to escape the trauma-based stress 
through the use or abuse of mood-altering substances and behaviors.  The 
reward centers stimulated through chemical or behavioral addiction-based 
action promote the release of dopamine which has shown to have atypical 
affects in individuals with emotional processing and reward processing 
center dysfunction (Wood et al., 2007).  Furthermore, fear and anxiety 
conditioning, or the behavior in which individuals learn to predict adverse 
events, has been shown to be affected by changes in the metabolism of 
dopamine in individuals with PTSD (Maren, 2001). Abnormalities in PFC 
dopamine transmission have been shown to be prevalent in pathological 
memory processing psychiatric disorders such as PTSD and opioid addiction.   
While substance use disorders (SUD) continue to be one of the most 
substantial coping methods used by PTSD survivors, coping mechanisms may 
include but are not limited to; sex, compulsive spending, gambling, exercise, 
eating, religion or anything else an individual finds the ability to immerse 
themselves in.  There is often a fine margin separating constructive forms of 
coping mechanisms from destructive ones (Howard, 2007). The portion of 




women who have suffered from sexual assault coupled with the co-morbidity 
of substance abuse is 30-59% (Najavits & Walsh, 2012). 
 
 Victims of sexual abuse have shown heightened predispositions to the 
development of sexually based addictions.  In a study following the recovery 
of over 1000 sexual addicts for 5 years beginning in 1985, researchers noted 
that among the sample population, 81% of the individuals had suffered sexual 
abuse.  Victims of sexual abuse, especially victims of childhood sexual 
assault, have a greater likelihood of developing sexual compulsions 
associated with the precipitating traumatic event (Howard, 2007).  Behaviors 
such as trauma repetition are often developed in an attempt to bring 
resolution to a traumatic event.  The individual will repeatedly attempt to 
seek a way to respond to a situation of past trauma through reenacting 
similar often painful behaviors in hopes of eliminating the fear associated 
with the precipitating event (Carnes, 1997).   
While there is overlap in the area of military sexual trauma (MST), acts 
of MST still possess the characteristics of traumatic acts of betrayal. 
Symptoms of PTSD developed in individuals affected by MST often are 
representative of this (Gilmore et al., 2016). MST survivors have higher rates 
of PTSD than women who have experienced other types of trauma. Rape and 
Intimate Partner Violence (IPV) that precipitate PTSD, are made even worse 




when it occurs in the military because of continued and unavoidable exposure 
and involvement with the perpetrator. The resulting PTSD may lead to 
greater risk of heart disease from change in health behaviors such as 
smoking, decreased physical activity and increased risk of SUDs (Lutwak & 
Dill 2013).  
SUDs are by far the most prevalent form of addiction among individuals 
suffering from PTSD. The high frequency of comorbidity chronic pain and 
PTSD provides a setting that intrinsically is conducive for the development of 
SUDs.  Apart from PTSD-related neurobiological influences on the 
susceptibility of an individual to develop a SUD, the increased likelihood to 
either self-medicate or seek prescription substances for chronic pain 
management provides a situation highly conducive for the initial use and 
continued abuse of drugs and alcohol (Morasco et al., 2013). 
  The increased access to pain management pharmaceuticals within the 
veteran population, has created controversially high levels of addiction to 
pharmaceuticals in particular those of an opiate nature.  This system of 
symptom correlation has revealed a need for special considerations regarding 
the assessment and treatment of chronic pain in particular (Gros, Szafranski, 
Brady, & Back, 2015).  While the seemingly sudden opiate addiction crisis in 
veterans has been the source of much public and media focus recently, the 
prevalence of self-medicating PTSD has been common much longer.  The 




comorbidity of alcohol disorders and PTSD in Vietnam era veterans had been 
shown to be approximately 70% (Carter, Capone, & Short, 2011).   
While addiction and the veteran population has already been the focus 
of vast study and publication (Figure 6) and there is a history of SUD 
correlated with PTSD, the recent epidemic of opiate addiction may prove to 
be more complex than non-opiate based addictions. This may be due to the 
nature of the dopamine receptor transmission similar in prefrontal cortex-
dependent memory processes such as PTSD and opiate related associative 
memories. A study in rats by Jing Li et al. (2018), showed an increase in 
sensitivity to normally non-rewarding morphine conditioning cues.  This 
increased sensitivity indicates a potentially heightened vulnerability to 
addiction for opiate based substances in individuals with PTSD when 
compared to the general population.  
 





Figure 6. Graph comparing articles published and cited in PubMed with titles 
containing both relevant keywords and addiction in total and over the past five 
years. All searches were run requiring the presence of both addiction and the 
relevant keywords in the publication title as of May 4, 2019.  
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stimulation of the HPA axis.  Cortisol binds to the intracellular glucocorticoid 
receptor in cells, thereby impacting the HPA axis causing negative feedback 
inhibition, which increases metabolic rate and alters immunosuppression 
(Neigh & Ali, 2016).  PTSD is often comorbid with high rates of 
cardiovascular, respiratory, inflammatory, gastrointestinal, and autoimmune 
disease (Boscarino, 2004).  PTSD’s interconnected effects on the immune and 
endocrine system may increase risk or accelerate progression of 
inflammatory and autoimmune diseases.  
 The effects of PTSD on the HPA axis and its increase in sympathetic 
activity stimulation can lead to an increase in cytokine production resulting 
in hyper-inflammatory states often co-morbid with PTSD. Chronic 
inflammation, as found in individuals with PTSD, often is found to be 
diagnosed alongside illnesses which include cardiovascular disease, asthma, 
fibromyalgia, chronic pain, hypothyroidism, rheumatoid arthritis, and 
psoriasis (Neigh & Ali, 2016).  Cytokines have also been shown to directly 
affect the HPA axis and central nervous system and recently these effects 
have been proposed to present PTSD symptom development (Furtado & 
Katzman, 2015). Currently, there is debate on whether inflammation is a 
predictor or a symptom of PTSD and whether inflammation may be the 
biological basis or sensitization factor to stress that precipitates PTSD as a 
result of the exposure to trauma (Neigh & Ali, 2016). 




 A recent focus of study in the area of PTSD has been the relationship of 
PTSD and immune function. A study of 666,269 Iraq war veterans showed 
twice the autoimmune disease risk when comparing those with PTSD to those 
without any psychiatric illness.  Furthermore, the same study showed that 
individuals with PTSD represented a 51% increase in autoimmune disease 
when compared to individuals with any other psychiatric illness (O’Donovan 
et al., 2015).  
  The role of cytokines could also be a potential source of the 
autoimmune function disorders often found co-morbid with PTSD due to their 
role in the differentiation of T cell subsets.  T cells have also been proposed 
as a potential indicator of vulnerability to psychiatric disorders.  A study 
conducted by Aiello et al. (2016), showed that prior to deployment, the 
responsiveness level of T cells to dexamethasone, a synthetic glucocorticoid, 
predicted PTSD and depression likelihood following deployment.  
Furthermore, decreases in functionality of regulatory T cells have been 
associated with auto immune disorders co-morbid with PTSD.  Individuals 
with PTSD have been shown to have an approximate 50% decrease in 
regulatory T cells when compared to the general population (Jergović et al., 
2014).   
 While immune function has been studied and shown to cause similar 
effects in both individuals with PTSD precipitating from sexual abuse and 




combat related trauma, there are discrepancies between the two groups when 
related to the general population due to the general gender composition of 
both groups (Breslau, 2001). In fact, as in other areas of relative interest, 
there is significantly more information regarding veterans and immune 
dysfunction (Figure 7).  Women are statistically far less likely to be combat 
veterans in the majority of world countries however, women are far more 
susceptible to being affected by PTSD, sexual abuse, and autoimmune 
diseases in their lifetimes.  In a study by O’Donovan et al. (2015), it was 
shown that of individuals studied with PTSD, three out of four individuals 
that were diagnosed with autoimmune conditions were women.  Due to the 
prior noted demographic discrepancies, there was not a statistically 
definitive change in magnitude of PTSD-related increased risk between 
Sexual Abuse survivors and combat war veterans with PTSD. Victims of 
Military Sexual Trauma however, displayed the highest risk of autoimmune 
diseases in both genders and was considered an independent risk factor when 
regarding the development of PTSD (Neigh & Ali, 2016). Veterans with MST-
related PTSD additionally have displayed a higher rate of comorbid SUD than 
general combat war veterans suffering from PTSD (Gilmore et al., 2016). 





Figure 7.  Graph comparing articles published and cited in PubMed with titles 
containing both relevant keywords and immune in total and over the past five 
years. All searches were run requiring the presence of both immune and the 
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Public Awareness and Understanding of PTSD 
One of the most powerful driving forces for the correct identification, 
research, understanding and treatment for a mental or physiological health 
issue is public awareness and understanding.  There are many common 
misconceptions involved with PTSD ranging from the belief that PTSD is a 
psychological weakness, to the idea that one can get PTSD from watching a 
violent movie.   
Issues plagued with negative preconceived stigmas or associations of 
shame have a long history of public avoidance or suppression.  Behaviors 
ranging from homosexuality to racism have a history of being hidden or 
obscured within societal focus often based on value-based comfort of a given 
culture’s norms. This cultural attitude towards complex issues also can be 
detrimental to the likelihood of individuals to seek treatment for negatively 
associated disorders or illnesses (Roman & Floyd, 1981). Both PTSD and 
sexual abuse have been greatly affected by historical societal views and 
stigmas which have led to confusion, misdiagnoses, and the debate of 
intrinsic definitions related to these areas of focus.  
 PTSD is a widespread biopsychosocial disorder that has been shown to 
affect approximately 5-10% of the population. Combat veterans of the 
Vietnam War showed rates of PTSD to be approximately 28% in those who 
were exposed to combat, and the disorder persisted in 11% of these 




individuals 40 years after the conflict had concluded (Yehuda et al., 2015).  
While the combat veteran population is a significant and atypical 
demographic displaying a substantial elevation in likelihood to develop PTSD, 
there is frequently a misconception of PTSD’s prevalence among civilians that 
can and has shown to be problematic. In fact, despite the fact that women are 
far less likely to be combat war veterans, they are twice as susceptible to 
developing PTSD.  Public awareness of the combat veteran population of PTSD 
has shaped the general understanding of the disorder leading to the 
disassociation of symptoms and their potential underlying cause in a large 
percentage of those suffering (Harik, Matteo, Hermann, & Hamblen, 2017). 
 Another largely detrimental barrier to identifying and treating PTSD is 
the social stigma that this disorder is a mental illness.  Research has shown 
that members of the combat war veteran population may feel embarrassed or 
ashamed to seek treatment resulting in a fear of being seen as weak. Couple 
this feeling of shame associated with PTSD with the shame and 
embarrassment often felt by victims of sexual abuse or even more so, 
childhood sexual abuse, and you have created a prison of socially-based fear 
that often can prevent survivors of PTSD from divulging sexual abuse 
experiences.  Recently, there have efforts to attempt to change the societal 
and cultural views on PTSD such as the “About Face” awareness campaign 
created by the VA.  Unfortunately, changing public opinion on issues of this 




nature take time and in the transition, many individuals will slip through the 
cracks (Reisman, 2016). 
 Another hindrance to ensuring the proper treatment of individuals is 
the constant historical fluctuation of both the name and understanding of this 
incredibly complex disorder.  PTSD has likely been around since humans 
developed emotional modulation itself, and there are records describing 
trauma based psychological disorders as far back as 490B.C. with the account 
of Greek historian Herodotus of an Athenian warrior who went blind when 
the soldier next to him was killed despite no physical injury to himself 
(Reisman, 2016).  The Civil War brought not only a new era of combat with 
rapid fire rifles and magnifying sights greatly magnifying the lethality of 
warfare, it also brought the first modern naming of “Da Costa’s syndrome” 
for what we now know as PTSD (Da Costa, 1951).  Soon there was “shell 
shock”, “battle fatigue”, “post-Vietnam syndrome” and then finally in the 
1970s, the diagnosis of PTSD was developed and made official in the 1980s 
(Reisman, 2016). The fact that a disorder affecting 5-10% of the population 
was rebranded five times in a period of only one hundred years certainly has 
not aided the holistic understanding of this condition for the general 
population.   
 When comparing statistics of individuals suffering from PTSD, there is 
a large discrepancy between the research focused on veterans and those who 




have developed PTSD from sexual abuse related precipitating traumas.  In an 
analysis of articles with titles containing keywords PTSD and some of the 
most common forms of precipitating trauma, there is an undeniable 
difference in total publications clearly distinguishing veteran related titles 
from other forms of trauma (Figure 8).  When these publication numbers are 
compared to demographics representative of the relative frequency of 
precipitating trauma causes, the discrepancy is even greater.  Despite the 
large number of publication titles containing PTSD and veteran, combat 
experiences in total are responsible for only 0.9% of cases of PTSD while 
32.9% of cases can be attributed to sexual-relationship violence (“The World 
Mental Health (WMH) Survey Initiative version of the World Health 
Organization (WHO) Composite International Diagnostic Interview (CIDI) - 
Kessler - 2004 - International Journal of Methods in Psychiatric Research - 
Wiley Online Library,”).  When relating these corresponding percentages to 
U.S. Population demographics, the lifetime prevalence totals of PTSD can be 
approximated for U.S. citizens as of March 2019 (Figure 9).  




Figure 8.  Graph comparing articles published and cited in PubMed with titles 
containing simplified relevant keywords in total and over the past five years. 
All searches were run requiring the presence of both PTSD and the relevant 
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Figure.9 Lifetime prevalence totals of PTSD in U.S. citizens based on 2019 U.S. 
census, population demographics (“US population by gender 2010-2024 | 
Statistic,”)  and distributions of conditional risk (“The World Mental Health 
(WMH) Survey Initiative version of the World Health Organization (WHO) 
Composite International Diagnostic Interview (CIDI) - Kessler - 2004 - 
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The discrepancy between specific demographics and PTSD publications 
could be either considered a failure of the promotion of awareness for this 
debilitating disorder or a testament of the success of recent public awareness 
campaigns in advocacy of veterans.  When the publication totals (Figure 8) 
are compared to the extrapolated lifetime prevalence totals of PTSD for 
specific forms of trauma in the U.S. (Figure 9), the exponentially greater 
focus on publication in the veteran population is undeniable (Figure 10).  As 
of March 2019, the ratio of the number of U.S. veterans to every publication 
containing both words PTSD and veteran in the title is approximately 252:1.  
Respectively, the number of individuals per publication for survivors of 
sexual assault is approximately 176,700:1 when related to publications 
containing both sexual assault and PTSD in the title. Numbers are marginally 
better when concerning survivors of rape resulting in approximately 59,240:1 
individuals to publications containing both the words rape and PTSD in the 
title.  
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Figure.10 Lifetime prevalence totals of PTSD in U.S. citizens based on 2019 
population demographics (“US population by gender 2010-2024 | Statistic,”)  
and distributions of conditional risk (“The World Mental Health (WMH) Survey 
Initiative version of the World Health Organization (WHO) Composite 
International Diagnostic Interview (CIDI) - Kessler - 2004 - International 
Journal of Methods in Psychiatric Research - Wiley Online Library,”) compared 
to total number of publications with respective title keywords on PubMed 
database as of March 2019. All searches were run requiring the presence of 
both addiction and the relevant keywords in the publication title as of May 4, 
2019. 
 
Discussion and Perspectives 
The prevalence of misunderstanding regarding the actual nature, 
symptoms, and causes of PTSD has been greatly detrimental to the task of 
helping those suffering from this disorder.  The cultural and societal stigmas 
associated with PTSD must be overcome in order to effectively progress.  
Without a more accurate and open understanding developed by the general 
public, not only will people suffer more deeply than they need, but the 
development of treatments and progress in combatting this disorder will be 
retarded.  The inconsistent identification of individuals with PTSD will 
continue to lead to inaccurate sample groups for study and research creating 




an increased challenge to the already incredibly difficult task of 
understanding and treating PTSD. 
The vast discrepancy between publications concerning veterans and 
PTSD compared to PTSD and other precipitating trauma highlights room for 
tremendous improvement in drawing attention to PTSD in non-veteran 
demographics. Regardless of whether the large discrepancy of veteran related 
PTSD publications is due to praise worthy pro-veteran public awareness 
campaigns, or are indicative of a general societal failure to other 
demographic groups such as survivors of sexual abuse, it is apparent that an 
enormous population of U.S. citizens are not being identified properly.  Even 
if the non-uniform distribution of publications is simply due to the study 
friendly controlled parameters and access intrinsic to military service, some 
of the successes in promoting PTSD awareness in veteran populations could 
undoubtedly be applied to the general public.  
 The proper diagnosis of those suffering of PTSD will require a more in-
depth look at the various demographics affected and in particular, those who 
have suffered sexual abuse in both adolescence and adulthood.  The 
staggering number of individuals who have come forward regarding their 
history of sexual abuse and still have not received proper diagnosis and 
treatment, highlights the failure of the medical and psychological treatment 
community in the treatment of this disorder in whole.  Furthermore, an effort 




to facilitate the comfort of the large suspected demographic of individuals 
with PTSD that have suffered sexual abuse and have been prevented from 
coming forward from fear, shame, or embarrassment, must be made.  A 
systematic effort must be put forth in the proactive identification of sexual 
abuse related PTSD in a safe and non-threatening way to ensure that this 
population gets the help and treatment that they need and deserve.   
 The highly prevalent comorbid disorders of addiction, immune function 
and chronic pain must be consciously and comprehensively understood and 
integrated in future treatment plans to maximize their effect.  The 
entanglement and overlap in the neurochemical characteristics and behavior 
of these four often comorbid disorders presents the potential for multiple 
disorders to be aided by a single treatment but also offers complications of 
maintaining overall neurochemical balance in these interconnected systems.  
Additionally, the high rates of addiction comorbidity with PTSD necessitates a 
strong need for the development of more successful non-narcotic treatments 
for chronic pain conditions that are prevalent among a high percentage of 
those affected.  The biopsychosocial nature of this disorder requires a 
multifaceted and comprehensive approach to treatment that coordinates 
psychological, chemical and physiological treatments.  
 The presence of two seemingly opposite phenotypes of emotional 
undermodulation and emotional overmodulation manifestations of PTSD 




necessitates a more holistic understanding in order to better help those 
affected.  The tendency of one phenotype developing more frequently than 
the other under certain situations or due to certain forms of precipitating 
trauma, such as long-term childhood sexual abuse survivors tending to 
present emotional undermodulation behaviors, leads to the potential for more 
concrete and definitive correlations to be identified in various cases of PTSD.  
Further study of these similarities and the inferred correlations may provide 
opportunities for more productive study and treatment development.   
 Overall, the recent increase of societal understanding and the reduction 
in negative stigma coupled with the exponential development in the fields of 
medicine and psychology, has yielded progressive advancement in combatting 
this tremendously prevalent and debilitating disorder.  There are however 
many opportunities to improve the effectiveness of future study and research 
through the more holistic and accurate understanding and communication of 
this incredibly prolific disorder. 
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